...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Quantitative Real-Time PCR Compared with pp65 Antigen Detection for Cytomegalovirus (CMV) in 1122 Blood Specimens from 77 Patients after Allogeneic Stem Cell Transplantation: Which Test Better Predicts CMV Disease Development?
【24h】

Quantitative Real-Time PCR Compared with pp65 Antigen Detection for Cytomegalovirus (CMV) in 1122 Blood Specimens from 77 Patients after Allogeneic Stem Cell Transplantation: Which Test Better Predicts CMV Disease Development?

机译:定量实时PCR与pp65抗原检测对异基因干细胞移植后77例患者的1122份血液样本中的巨细胞病毒(CMV)进行比较:哪种测试能更好地预测CMV疾病的发展?

获取原文

摘要

Cytomegalovirus (CMV) can compromise the life of patients who are immunosuppressed after organ transplantation or who have acquired immunodeficiency syndrome. CMV infections or reactivations can be successfully treated, provided treatment is instituted early in the course of developing disease. Current assays to detect the CMV pp65 antigen in peripheral blood leukocytes or CMV DNA by qualitative PCR of leukocytes or plasma can be slow and tedious (1)(2)(3). Antigen detection is limited by the availability of sufficient white blood cell numbers and is impossible to perform on leukopenic patients. In addition, blood for antigen detection cannot be stored for long periods because white blood cells need to be intact for staining procedures (4)(5). PCR techniques detect relatively stable double-stranded DNA present in the plasma or whole blood regardless of storage conditions or cell integrity, but qualitative PCR assays are not useful for follow-up studies of patients, and they do not allow the determination of viral load, which is useful for prognosis.In this study we compared quantitative real-time PCR (6)(7) with conventional pp65 antigen staining among 77 patients (1122 blood samples) surviving more than 30 days after stem cell transplantation (see Table 1 in the Data Supplement that accompanies the online version of this Technical Brief at http://www.clinchem.org/content/vol49/issue10/). In a retrospective study, results of the two assays were compared, and their sensitivity and specificity for predicting CMV disease were calculated.All patients were transplanted in the Virchow Klinikum (Berlin, Germany) between January 1998 and March 2001 (see Table 1 in the online Data supplement). Five patients developed CMV organ disease, which included pneumonitis and hepatitis (n = 1), hepatitis (n = 1), enteritis (n = 2), and retinitis (n = 1). Seven additional patients developed thrombo- and leukopenia not explained by other conditions. …
机译:巨细胞病毒(CMV)可能会损害器官移植后受到免疫抑制或获得性免疫缺陷综合症的患者的生活。只要在疾病发展过程中尽早进行治疗,就可以成功治疗CMV感染或再激活。当前通过白细胞或血浆的定性PCR检测外周血白细胞或CMV DNA中的CMV pp65抗原的测定可能是缓慢而乏味的(1)(2)(3)。抗原检测受到足够的白细胞数量的限制,不可能对白细胞减少症患者进行。此外,用于抗原检测的血液不能长期保存,因为染色过程需要完整保存白细胞(4)(5)。 PCR技术可检测血浆或全血中存在的相对稳定的双链DNA,而不论其储存条件或细胞完整性如何,但定性PCR分析不适用于患者的后续研究,并且无法确定病毒载量,在这项研究中,我们比较了在干细胞移植后存活30天以上的77例患者(1122血样)中的实时荧光定量PCR(6)(7)与常规pp65抗原染色的比较(见表1)。本技术简介的在线版本随附的数据补编(http://www.clinchem.org/content/vol49/issue10/)。在一项回顾性研究中,比较了这两种测定的结果,并计算了它们预测CMV疾病的敏感性和特异性.1998年1月至2001年3月之间,所有患者均被移植到Virchow Klinikum(德国柏林)中(参见表1)。在线数据补充)。五名患者发生了CMV器官疾病,包括肺炎和肝炎(n = 1),肝炎(n = 1),肠炎(n = 2)和视网膜炎(n = 1)。另外七名患者出现了其他情况无法解释的血栓和白细胞减少症。 …

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号